GLP-1 drugs linked to bigger jump in women’s employment than a college degree
A Harvard study indicates that unemployed women who began taking GLP-1 weight-loss drugs saw a 27-percentage-point increase in employment 18 months later. The research suggests that weight loss may influence employer perception, potentially mitigating the 'obesity penalty' in the labor market.
Why it matters
The findings highlight the intersection of medical advancements, social bias, and economic outcomes for women in the workforce.
Harvard study links GLP-1 weight-loss drugs to a 27-point jump in women's employment — bigger than a college degree gap Victoria Vesovski Sat, August 8, 2026 at 8:30 AM EDT 5 min read shutterstock.com / Pietukhova Pretty privilege may be alive and well. Apparently, so is skinny privilege.
For years, economists have documented what they call the "obesity penalty" — the social and financial disadvantages people can face because of their weight. Now, the rise of GLP-1 medications is giving researchers a new way to measure just how much appearance may shape someone's economic prospects.
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in